These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12562233)

  • 1. Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity.
    Bejarano PA; Mousavi F
    Arch Pathol Lab Med; 2003 Feb; 127(2):193-5. PubMed ID: 12562233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
    Srodon M; Westra WH
    Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
    Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
    Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases].
    Romeike BF; Feiden W
    Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids.
    Afify AM; al-Khafaji BM
    Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis.
    Holzinger A; Dingle S; Bejarano PA; Miller MA; Weaver TE; DiLauro R; Whitsett JA
    Hybridoma; 1996 Feb; 15(1):49-53. PubMed ID: 9064286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique.
    Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH
    J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
    Roh MS; Hong SH
    J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKX3.1 as a marker of prostatic origin in metastatic tumors.
    Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
    Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1.
    Bohinski RJ; Bejarano PA; Balko G; Warnick RE; Whitsett JA
    J Neurooncol; 1998 Dec; 40(3):227-31. PubMed ID: 10066094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
    Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
    Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
    Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
    Zamecnik J; Kodet R
    Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.
    Kaufmann O; Dietel M
    Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
    Kaufmann O; Dietel M
    Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
    Ng WK; Chow JC; Ng PK
    Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.